As of 2025-09-18, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (7.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -365.6%.
The range of the Relative Valuation is (7.18) - (8.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 18.9x | 13.9x |
| Forward P/E multiples | 13.9x - 17.3x | 14.1x |
| Fair Price | (7.18) - (8.92) | (7.22) |
| Upside | -364.0% - -427.8% | -365.6% |
| Date | P/E |
| 2025-09-16 | -5.37 |
| 2025-09-15 | -5.39 |
| 2025-09-12 | -5.50 |
| 2025-09-11 | -5.41 |
| 2025-09-10 | -5.04 |
| 2025-09-09 | -4.92 |
| 2025-09-08 | -4.86 |
| 2025-09-05 | -5.19 |
| 2025-09-04 | -4.90 |
| 2025-09-03 | -4.71 |
| 2025-09-02 | -4.50 |
| 2025-08-29 | -4.30 |
| 2025-08-28 | -4.28 |
| 2025-08-27 | -4.23 |
| 2025-08-26 | -4.24 |
| 2025-08-25 | -4.17 |
| 2025-08-22 | -4.21 |
| 2025-08-21 | -4.13 |
| 2025-08-20 | -3.97 |
| 2025-08-19 | -3.95 |
| 2025-08-18 | -4.07 |
| 2025-08-15 | -3.97 |
| 2025-08-14 | -4.01 |
| 2025-08-13 | -3.76 |
| 2025-08-12 | -3.47 |
| 2025-08-11 | -3.58 |
| 2025-08-08 | -3.62 |
| 2025-08-07 | -3.51 |
| 2025-08-06 | -3.72 |
| 2025-08-05 | -3.14 |
| 2025-08-04 | -2.89 |
| 2025-08-01 | -2.71 |
| 2025-07-31 | -2.75 |
| 2025-07-30 | -2.73 |
| 2025-07-29 | -2.85 |
| 2025-07-28 | -3.08 |
| 2025-07-25 | -2.93 |
| 2025-07-24 | -2.89 |
| 2025-07-23 | -2.58 |
| 2025-07-22 | -2.36 |
| 2025-07-21 | -2.23 |
| 2025-07-18 | -2.27 |
| 2025-07-17 | -2.40 |
| 2025-07-16 | -2.17 |
| 2025-07-15 | -2.19 |
| 2025-07-14 | -2.29 |
| 2025-07-11 | -2.31 |
| 2025-07-10 | -2.40 |
| 2025-07-09 | -2.38 |
| 2025-07-08 | -2.27 |